Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Recruiting

Phase 3

PD-1/PD-L1 InhibitorEvaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Sponsor:

Jason J. Luke, MD

Code:

NCT04157985

Conditions

Advanced Solid Tumors

NSCLC

Bladder Cancer

HNSCC

Renal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Continue PD-1/PD-L1 Inhibitors treatment

Discontinue PD-1/PD-L1-1 inhibitor

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-02. This information was provided to ClinicalTrials.gov by Jason J. Luke, MD on 2025-03-25.